Latest / UF Health MedEd Cast / The Role Testosterone Plays in Male Fertility?
Transcript
- 0:26Melanie (Host): Welcome to UF Health Med EdCast with UF Health Shan's Hospital.
- 0:30I'm Melanie Cole, and today we're talking about testosterone and fertility.
- 0:35Joining me is Dr.
- 0:36Kevin Campbell.
- 0:37He's an assistant clinical professor and an associate Medical Director
- 0:41in the Department of Urology at the University of Florida College of Medicine.
- 0:45Dr.
- 0:46Campbell, it's such a pleasure to have you join us today.
- 0:48Let's just start with kind of how common in the prevalence is testosterone
- 0:53deficiency and disorders in men?
- 0:56Kevin Campbell, MD: Absolutely.
- 0:57And Melanie, thanks for having me.
- 0:59It's a pleasure to be here today.
- 1:01So testosterone and, the implications of having high and low testosterone,
- 1:06are really, really, uh, at the forefront of, what I practice on
- 1:09a day-to-day in clinical medicine.
- 1:11And it's a topic that's, near to my clinical interests and heart.
- 1:13So if we're looking at.
- 1:15The number of people who have testosterone deficiency or, low testosterone,
- 1:21depending on what clinical picture you look at, you're gonna be seeing somewhere
- 1:24from like 5% all the way up to 20%.
- 1:28So it's not without, a big presence in the general community.
- 1:31And you likely know somebody who either has low testosterone or
- 1:36testosterone deficiency or is being treated for testosterone
- 1:39deficiency and may not even know it.
- 1:41Melanie (Host): Well, since it's so common, speak a little bit about what
- 1:44would send a man to a physician, whether it's his primary care or urologist.
- 1:50Tell us some of the signs and symptoms that they might notice
- 1:53or that a partner might notice.
- 1:55I.
- 1:55Kevin Campbell, MD: Absolutely.
- 1:56there's really two main drivers of men to the physician, especially
- 2:01for younger, healthier men usually, and that's fertility or sterility.
- 2:05Men are either trying to, either get a, a vasectomy or, or worried about
- 2:09their reproductive healthcare or something's going wrong and they're
- 2:13worried about their testosterone.
- 2:14And a lot of the times the signs and symptoms may be difficulty with pregnancy.
- 2:19It may be increased fatigue, it may be low sex drive.
- 2:23Low muscle mass, decreased, ability to achieve an erection.
- 2:27Now they're starting to have all this adipose or fat tissue around
- 2:30their abdomen And also, uh, sometimes orgasmic or other sexual disorders.
- 2:35And the thing we worry about with these is we try to screen them early
- 2:38because sometimes they might be a sign or symptom of something greater like a.
- 2:42Pituitary pathology or an endocrine disorder, or testosterone deficiency.
- 2:48So we have to rule out some of the scary things, to get down to it.
- 2:51And so we're really trying to listen to what the patient's are
- 2:54saying when they're coming to us.
- 2:56Melanie (Host): And then how is diagnosis made?
- 2:59Kevin Campbell, MD: So diagnosis is made with signs and
- 3:01symptoms of low testosterone.
- 3:03A lot of those symptoms we talk about like fatigue, decreased energy,
- 3:07decreased muscle mass, poor bone health, sometimes easy fractures.
- 3:11so Those are the, subjective, aspects.
- 3:14And then they have to have a low.
- 3:15Morning testosterone value.
- 3:17So testosterone, it's highest in the morning.
- 3:20It peaks with a pulse eye release of GNRH in your pituitary, and
- 3:24hypothalamus to then make LH and FSH and your LH goes to your testicles
- 3:29and tells 'em to make testosterone.
- 3:31And so that's signals highest in the morning And then starts
- 3:33to decrease throughout the day.
- 3:35So we do try to get a morning testosterone before 10:00 AM and depending on what
- 3:40reference range or what lab value you're using, you're gonna have some.
- 3:44Degree of, variation with that set number.
- 3:47So in many labs, and FDA will say that's around 300 nanograms per deciliter.
- 3:52And a testosterone below that, along with the signs and symptoms would,
- 3:56give you reason to say somebody has testosterone deficiency.
- 3:59Now if you look at, the Endocrine Society guidelines, they actually
- 4:03take their testosterone number and use it as a statistical.
- 4:07Reference and take two standard deviations beyond what's normal.
- 4:11And so their reference range is gonna be around like two 50 to to nine 50 or so.
- 4:15So you do see some change in the reference.
- 4:16And then even with the, the Androgen Society And the Society of the
- 4:20Aging male have used cutoffs as high as, three 50 in the past.
- 4:24And so a lot of This is really geared at signs and symptoms
- 4:27because not everybody has the same.
- 4:29Need for a certain level of testosterone.
- 4:32Not everyone has the same androgen receptors, so we have to look at the
- 4:36objective And the subjective together.
- 4:38Melanie (Host): Well, thank you for that.
- 4:39So, Dr.
- 4:40Campbell, as we look at a quick overview of the history of a UA
- 4:44guidelines on male infertility, speak a little bit about the priority topics
- 4:49addressed in the guidelines as they are today, and those statements.
- 4:54Kevin Campbell, MD: This is a really timely question.
- 4:55I'm glad you brought this up.
- 4:57The first guidelines came out in 2020, and prior to that we had a
- 5:00bunch of consensus statements and a lot of variations of different
- 5:04particular aspects of male infertility.
- 5:06But we didn't have any overarching or just, larger guidelines.
- 5:11That men could look at.
- 5:12And then those were updated in 2024 to continue to stay relevant with
- 5:16a, just a couple of major changes.
- 5:18But really the guidelines start And the work of starts with an evaluation,
- 5:22a history physical of both partners, both the male And the female partner.
- 5:26Because oftentimes, if we look at the breakdowns of what causes fertility,
- 5:30there's a 30% male factor alone, 20% combined factor, and a 50% female factor.
- 5:37So if you do some back of the envelope calculations and fudge the factors a
- 5:40little bit, you can say that the male aspect contributes to at least 50% of
- 5:45the infertility aspects for couples.
- 5:48And 15% of couples will have degree of infertility.
- 5:51And it might be something as, routine as a.
- 5:55Different type of lifestyle modification that a patient may employ that we find
- 5:59on the initial history and physical.
- 6:01There might be a medication that someone's taking, or it might be in the history that
- 6:05someone had some sort of chemotherapeutic or radiation that then may limit to what
- 6:10degree we can restore sperm production or lend us to recommend surgery over
- 6:16different stimulatory techniques.
- 6:17So the first and biggest part of the workup is going to be the history.
- 6:22And discussing with the patient And also finding their goals.
- 6:25We have some couples who come in who are very young and they're just
- 6:28starting to try their fertility journey and try to conceive, And so
- 6:32there's a little bit more leeway.
- 6:34We have some financial constraints as well sometimes, so we have
- 6:37to take that all into account.
- 6:38We.
- 6:39Whereas if we have a couple that might be a decade or two older than that,
- 6:42we're discussing potentially assisted reproductive therapies or ways to
- 6:46optimize the fertility outcomes when we don't have the same sort of flexibility
- 6:49that we may have with another couple.
- 6:51So a lot of the basic workup for fertility a.
- 6:54Goes into what I call the big three, and that's gonna be the
- 6:57history and physical blood work.
- 6:59So we can see how the hypothalamus And the testicles are talking
- 7:02to each other And the pituitary and and how they all feed back.
- 7:06And then also a semen analysis.
- 7:08And when we get those big three, we can make a recommendation
- 7:11of how to optimize fertility.
- 7:13No one test can really say someone is fertile or infertile, but we
- 7:17take all these things together to come up with our recommendations.
- 7:21Melanie (Host): That was very comprehensive.
- 7:22So first-line management of testosterone disorders.
- 7:27Tell us a little bit about some of the therapies that are available right now.
- 7:31Kevin Campbell, MD: Certainly, I think a lot of what goes into first-line
- 7:34therapy when people are thinking about testosterone deficiency is going
- 7:39to be giving somebody testosterone, and That is often the case.
- 7:43However, one of the first steps that we have to evaluate is why
- 7:46someone has low testosterone.
- 7:48Is it a issue with the testicles?
- 7:51Is it a issue with the pituitary?
- 7:53Is it an issue with the hypothalamus?
- 7:54Is it a, systematic or global insult to a patient's physiology?
- 7:59are they on some, chemotherapeutic or some medication that causes
- 8:03them to have blunting of this, HPG access or decreased testosterone?
- 8:08there's bounces down, even after starting some medications that men often will use.
- 8:13So it's important that we do, again, this history and physical and do this
- 8:17workup, the mainstay of treatment.
- 8:20It is often going to be replacement of testosterone or stimulatory therapy
- 8:24if someone's trying to conceive.
- 8:26We don't want to give that person testosterone right off the bat
- 8:29because that can shut down their natural production of intra testicular
- 8:33testosterone as well as sperm production.
- 8:35So.
- 8:36Many men who go on testosterone who are trying to conceive will
- 8:40drop their sperm counts to zero.
- 8:42Now we know that testosterone is not a contraceptive And that
- 8:45people will get pregnant on testosterone, but it doesn't optimize
- 8:49someone's ability to get pregnant.
- 8:50So we have to take that into account.
- 8:52And there are different, there's different therapies to, depending on
- 8:54what hormones, are elevated or normal.
- 8:58That we can employ.
- 8:58So if someone's F, s, H and LH are say in the normal range, we might
- 9:02try and stimulate that with say, a ER like Clomophine or in Clomophine
- 9:06or Tamoxifen, or even give someone FSH or HCG, which is an analog of lh.
- 9:12To try and stimulate testosterone production in the testicles.
- 9:16Now, if that's not an issue or we're looking at an androgen deficiency or
- 9:21a testosterone deficiency for, the aging male, we are gonna have a, more
- 9:26robust discussion about the different types of formulations of testosterone.
- 9:30There's almost a million formulations of testosterone out there, And that
- 9:33That is been a little bit facetious, but there are quite a few, many of
- 9:37which are all different types of, conjugated esters of testosterone.
- 9:41Different lengths which may last a little bit longer in the body.
- 9:44we will oftentimes use a injection either intramuscular, subcutaneous
- 9:48that may last for a week or, two weeks or, or even 48 hours in some
- 9:53of the shorter acting testosterones.
- 9:55And then there's gels or creams that men will put either on their, upper
- 9:59outer chest over the subclavians to absorb or the inner thigh or
- 10:03even on the forearms, to absorb.
- 10:05And that would be on a daily application.
- 10:07So a lot of what goes into our first-line therapy is tailoring it to the patient.
- 10:12I think it would be, inappropriate for us to give a, overall recommendation
- 10:17of what works for everybody.
- 10:18Because if we have the.
- 10:20Gardner who's going outside every morning and is going to be sweating and has
- 10:23to be up at, say, you know, 6:00 AM or when the sun's coming up, they're gonna
- 10:26sweat off a lot of this testosterone gel where we might have somebody who is,
- 10:31who has a fear of needles And so they don't, appreciate the idea of giving
- 10:34themselves injection or maybe a tremor.
- 10:36and once we've established a response to testosterone, we might move on
- 10:40to pellets or even an intranasal gel or many other, applications as well.
- 10:44So that's generally how we approach the first-line for testosterone management.
- 10:49Melanie (Host): Well, thank you for that Dr.
- 10:50Campbell.
- 10:51So speak a little bit with all of these available therapies and more
- 10:55tools in your toolbox all the time.
- 10:58What factors should.
- 11:00Other providers consider before recommending some of these therapies,
- 11:04speak a little bit about any side effects, complications you
- 11:07discuss with the patient's patient preference and lifestyle preference.
- 11:13Speak about to other providers about what they should consider when they're looking
- 11:17at all of these different therapies.
- 11:19Kevin Campbell, MD: Yeah.
- 11:20Thanks for bringing this up, Melanie.
- 11:21This is very important because I think.
- 11:24One testosterone application for one person is not the same for the next.
- 11:28And so when someone comes to see me, we're gonna talk about the risk
- 11:33and benefits of testosterone And then the modalities of treatment.
- 11:36So let's talk about the risks and benefits first.
- 11:39So.
- 11:40There's definitive evidence to say that testosterone, if it's low And we
- 11:43replace that, that can help with libido.
- 11:46It can help with sex drive, it can help with increasing muscle mass and
- 11:50decreasing visceral adipose tissue.
- 11:52It can help with bone density and prevent osteoporosis, and it can
- 11:56help with insulin sensitivity.
- 11:57There Sporadic reports of it, helping also with mental cognition and brain fog.
- 12:03Those are a little bit less reported in large studies and
- 12:07having definitive evidence.
- 12:09But we do have a lot of anecdotal evidence there and there are also risks involved.
- 12:14Testosterone is a molecule that's seen by the body, so it's, we
- 12:18call bioidentical, so it's not.
- 12:20As high-risk as other synthetic molecules, but it does have an
- 12:23effect on a body's physiology.
- 12:25It can go to your bone marrow and tell it to make more red blood cells.
- 12:28So if someone is undergoing testosterone therapy and not undergoing monitoring,
- 12:33they can get polycythemia, they can have increased hematocrit,
- 12:37they can put themselves at-risk for blood clots, for their legs, for
- 12:40their hearts, and brains as well.
- 12:41So there's a Non insignificant risk for heart attack, stroke, DBTs.
- 12:46if someone has, polycythemia that's unchecked.
- 12:49Now, testosterone has been proven to cause these, but secondarily, if
- 12:52it's raising the hematocrit And that goes unchecked, it can lead to it.
- 12:55So that's very important as a risk.
- 12:57Another risk that.
- 12:59It's very popular as prostate health.
- 13:01So there is a misconception that testosterone causes prostate cancer.
- 13:06Testosterone has never been known to cause prostate cancer since it's
- 13:10been first synthesized in 1935.
- 13:13So what we worry about though is that if someone has prostate cancer
- 13:17and it goes to other parts of the body metastasizes, well then one of
- 13:20the ways we know we can actually.
- 13:22stop that spread or help kill the cancer is to starve it of testosterone.
- 13:26So we do think of testosterone, in that regards as being a.
- 13:30Lack of testosterone is a treatment for some prostate cancers and it can
- 13:34So, it can help grow prostate cells.
- 13:36So if someone's hypogonadal, they have low testosterone and they have potentially
- 13:40a smaller prostate or a prostate that's not fully saturated by their androgens
- 13:44'cause their testosterone's low.
- 13:45And now you give someone testosterone, that prostate can respond in a
- 13:49more robust way than it has been.
- 13:51And so some people will see urinary tract symptoms like, like an increased
- 13:55prostate size that can cause, what we call lutz, or increased urinary F frequency
- 13:58hesitancy and growth of the prostate.
- 14:01And with that comes an elevation of PSA, because if you have more
- 14:04prostate tissue, you make more PSA.
- 14:07Now it does not, again cause prostate cancer, but it is something we screen
- 14:11for in this population because we're already seeing them And we wanna make sure
- 14:15that if we're growing the prostate, if there's any already present, significant
- 14:19prostate cancer, that we can catch it early and treat it appropriately.
- 14:23Some of the other effects that we see or side effects with testosterone therapy
- 14:27is how your body recycles testosterone.
- 14:29There's enzymes in your, your natural adipose tissue and fat,
- 14:33and your liver and brain, called aromatase, which will take your
- 14:37testosterone and turn it into estrogen.
- 14:39And so if that estrogen gets very high, that can also put
- 14:42you at-risk for blood clots.
- 14:43And it can decrease sex drive, it can decrease, erectile quality.
- 14:48And so we have to take that into account and, monitor estrogen and
- 14:52even put someone on an estrogen blocker if it gets too high.
- 14:55But we also don't want to go too low because then that can put
- 14:57someone at-risk for osteoporosis.
- 15:00Some other issues we see with testosterone management are increased acne because
- 15:05there's increased oil production by the skin think of someone when they're
- 15:07going through puberty and, and they're getting these testosterone surges.
- 15:10The, the skin produces more oil and sebum And that can cause
- 15:13blockages of all the hair follicles.
- 15:16Then, it's other times we can even see some hair thinning.
- 15:18So if someone is prone to male pattern baldness.
- 15:22Testosterone if, given in a, higher state, it can lead
- 15:26to advanced in hair loss.
- 15:28So all these are things we're taking into effect.
- 15:30Now, when someone goes on testosterone, they may have a job that may not
- 15:36allow them to have a daily application.
- 15:39Like, let's say someone's traveling a lot and it's harder to travel with
- 15:41hypodermic syringes or needles, then we may say, okay, a, daily application with
- 15:46a gel or a cream will be best for you.
- 15:48Versus if someone has a, maybe a deployment job or maybe a, job
- 15:53that would say, let's go ahead and use a weekly syringe or even a
- 15:57biweekly injection of testosterone, then certainly they can use that.
- 16:01some providers, will also favor putting in pellets, for patient's.
- 16:05And these last for about three months before they dissolve.
- 16:08And so some patient's like the kind of the set it and forget it.
- 16:12So all these are things that we, consider Some of the newer testosterones are
- 16:15the oral formulations And the 1980s oral formulations were, were very
- 16:19popular too, but they were alkylated.
- 16:21And so every time somebody would take testosterone, it was putting a
- 16:24little bit of pressure on the liver.
- 16:25And so we.
- 16:26Quickly, moved and pivoted from that application.
- 16:30But now there are newer formulations.
- 16:31There's three of 'em that are out now.
- 16:33These types of testosterone, ECNO eight that get absorbed
- 16:36with the lymphatics in the gut.
- 16:38So you take them, once or twice a day and it brings your testosterone up.
- 16:42So if someone doesn't wanna do a gel or a cream or an injection,
- 16:45we have different options now.
- 16:47So the future is bright for testosterone management.
- 16:50Melanie (Host): Wow.
- 16:51It's such an exciting time in your field, Dr.
- 16:54Campbell, and you are such a wealth of knowledge.
- 16:56As we wrap up, I'd like you to speak a little bit about lifestyle factors,
- 17:00relationships between infertility and general health, and how you, as you
- 17:06summarize, with shared decision-making.
- 17:09Form your patient's of all of these different therapies And what goes
- 17:13into the treatment options available.
- 17:17Kevin Campbell, MD: Yes, This is really important because when
- 17:19someone's coming in to be evaluated for either testosterone deficiency
- 17:24or fertility, it's not always the.
- 17:28Spend all, be all of that particular person.
- 17:31This is oftentimes the peak of an iceberg where there's something underlying that
- 17:35we really need to evaluate and treat.
- 17:37We know that men who have increased fertility issues have an
- 17:41increased morbidity and mortality.
- 17:43There's a increase by one to 3%, higher mortality rate in
- 17:47the infertility population.
- 17:49And that might be because there's some overlying condition that we identify.
- 17:53Sometimes There's no overlying condition that's identifiable.
- 17:56But we do know that.
- 17:58And treatment does have a burden as well.
- 18:00So we have to keep all those things in mind.
- 18:02When, evaluating for patient's for fertility.
- 18:05Now sometimes people will come in and they understand their fertility
- 18:08burden, but don't necessarily want treatment and just want answers.
- 18:12And so really the workup is going to be dependent on the back and
- 18:15forth with patient and provider.
- 18:17So.
- 18:18I would really harp on, this patient and physician model where we really
- 18:22try to hear what the patient's saying and, and meet them where they're at.
- 18:25Because if we're telling somebody that has low libido and decreased erectile quality
- 18:31and decreased adipose, or increased adipose tissue, decreased muscle mass
- 18:36that they need to go on testosterone.
- 18:38But then they say, Hey, but I'm trying to also start a family, or I
- 18:41wanna get pregnant in a couple years.
- 18:43Well, now we've just added a degree of complexity that we can't overlook.
- 18:46So we have to keep all these things in mind when going
- 18:49forward with our patient care.
- 18:50I.
- 18:51Melanie (Host): Great information.
- 18:52Dr.
- 18:52Campbell.
- 18:53Thank you again for joining us and sharing your incredible expertise
- 18:58with other providers today.
- 18:59And to learn more, you can visit uf health.org/specialties/urology,
- 19:06or to learn more about this and other healthcare topics at UF Health
- 19:10Shands Hospital, you can always visit innovation dot uf health.org.
- 19:15That concludes today's episode of UF Health Med EdCast
- 19:19with UF Health Han Hospital.
- 19:21I'm Melanie Cole.